Clinical trials
Phase 2 Heart Defects, Congenital trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Michigan | 2 |
| Aymen N Naguib | 1 |
| Baylor College of Medicine | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's Hospital of Philadelphia | 1 |
| John M Costello | 1 |
| Loma Linda University | 1 |
| MedImmune LLC | 1 |
| Nationwide Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 19 |
| Univentricular Heart | 3 |
| Heart Diseases | 2 |
| Heart Failure | 2 |
| Hypoplastic Left Heart Syndrome | 2 |
| Acute Kidney Injury | 1 |
| Anemia | 1 |
| Blood Platelet Disorders | 1 |
| Cardiac Output, Low | 1 |
| Cardiomyopathies | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.